Global STD Diagnosis Market Research and Forecasts 2017-2022

  • ID: 4450947
  • Report
  • Region: Global
  • Orion Market Research Private Limited
15 % OFF
until Dec 31st 2018
1 of 4

FEATURED COMPANIES

  • Abbott Laboratories
  • Alere Inc.
  • Bcr Biotech Inc.
  • Biomerieux
  • Cepheid Inc.
  • Diasorin
  • MORE
Market Insights

The Global STD (Sexually Transmitted Disease) Diagnosis Market is expected to grow at a CAGR of 8.7% during the forecast period (2017-2022). A group of illnesses that can be transmitted from one person to another through the sharing of body fluids, vaginal fluids, blood and so forth is known as STD (Sexually Transmitted Diseases). STD include more than 25-30 infectious diseases that are spread through sexual activities. In lack of treatment or awareness these diseases can lead to major health problems such as not being able to get pregnant (infertility), permanent brain damage, heart disease, cancer, and even death as STD has no early symptoms. A person exposed to STD must undergo a diagnosis for sexually transmitted diseases in a hospital or a health clinic. Common sexual transmitted diseases include human immunodeficiency virus, chlamydia, gonorrhea, syphilis, herpes simplex virus, human papilloma virus and so on.

Global STD Diagnosis Market is growing at a faster pace owing to the rising incidences of unprotected sex, lack of awareness and so forth. The rising number of patients suffering from STD includes people from age group of 15 years to 24 years. Recommendations from various regulatory authorities for annual STD screening for sexually active men and women are expected to further fuel the demand for STD testing. STD screening services are now widely covered under healthcare services and are likely to augment the growth of the global STD testing market. Regulatory authorities such as the WHO, have outlined strategies for the prevention and control of STDs. Research activities are being carried out to understand the growing prevalence of STDs, particularly Syphilis, among bisexual men and gay. All of these factors are anticipated to boost the growth of the global STD (sexually transmitted disease) diagnosis market during the forecast period. Moreover, lack of knowledge related to STD and poor infrastructure provision such as labs, and equipment in underdeveloped countries such as West Africa acts as a hindering agent and blocks the growth of the global STD (Sexually Transmitted Disease) Diagnosis market.

Geographical Insights

Geographically, the market is divided into North America, Europe, Asia Pacific and Rest of the World. North America is expected to dominate the STD diagnosis market owing to favorable government initiatives in the US for STDs diagnostics, favorable healthcare infrastructure and high awareness levels. However, the demand for HPV (human papillomavirus) tests has been increasing in the past few years owing to the rising awareness to examine the growth of cancerous cell within the cervix. Asia Pacific is anticipated to be the fastest growing region for the STD diagnosis market during the forecast period due to rapid spread of human papilloma virus infection among the female population in this region. This region is accounted as a leading market for STD (Sexually Transmitted Disease) Diagnosis in terms of growth. Additionally, the rising awareness towards personal care in emerging economies of India and China is anticipated to boost the STD diagnosis market during the forecast period.

Competitive Insights

The major players profiled in the Global STD (Sexually Transmitted Disease) Diagnosis Market include- Abbott Laboratories, Affymetrix, Inc., Alere Inc., Aposcience AG, BCR Biotech Inc., Becton Dickinson And Company, Biocartis SA, Biomerieux, Bio-Rad Laboratories Inc., Cepheid Inc., Danaher Corporation, DiaSorin, Exogen Biotechnology, Inc., GenMark Diagnostics, Hologic, Inc., OraSure Technologies, Qualigen Inc., Quidel Corporation, Roche Diagnostics, Thermo Fisher Scientific Inc. and so on.

Market Segmentation

Global STD (Sexually Transmitted Disease) Diagnosis Market is segmented on the basis of disease indication, testing devices, technology, end users and regional outlook.

1. Global STD (Sexually Transmitted Disease) Diagnosis Market Research and Analysis, by disease indication
2. Global STD (Sexually Transmitted Disease) Diagnosis Market Research and Analysis, by testing devices
3. Global STD (Sexually Transmitted Disease) Diagnosis Market Research and Analysis, by technology
4. Global STD (Sexually Transmitted Disease) Diagnosis Market Research and Analysis, by End Users
5. Global STD (Sexually Transmitted Disease) Diagnosis Market Research and Analysis, by Region

This report covers:
  • Comprehensive research methodology of Global STD (Sexually Transmitted Disease) Diagnosis Market
  • This report also includes detailed and extensive market overview with key analyst insights
  • Exhaustive analysis of macro and micro factors influencing the market guided by key recommendations
  • Analysis of regional regulations and other government policies impacting the Global STD (Sexually Transmitted Disease) Diagnosis Market
  • Insights about market determinants which are stimulating the Global STD (Sexually Transmitted Disease) Diagnosis Market
  • Detailed and extensive market segments with regional distribution of forecasted revenues
  • Extensive profiles and recent developments of market players
READ MORE
Note: Product cover images may vary from those shown
2 of 4

FEATURED COMPANIES

  • Abbott Laboratories
  • Alere Inc.
  • Bcr Biotech Inc.
  • Biomerieux
  • Cepheid Inc.
  • Diasorin
  • MORE
1. Report Summary
1.1. Research Methods and Tools
1.2. Market Breakdown
1.2.1. by Segments
1.2.2. by Geography
1.2.3. by Stakeholders
1.2.4. Exceptions

2. Market Overview and Insights
2.1. Definition
2.2. Analyst Insights & Current Market Trends
2.2.1. Key Findings
2.2.2. Recommendation
2.2.3. Conclusion
2.3. Regulation
2.3.1.1. United States
2.3.1.2. European Union
2.3.1.3. China
2.3.1.4. India

3. Market Determinant
3.1. Motivators
3.1.1. Rising Incidences and Prevalence of Aids and Other Stds
3.1.2. Growing Incidence and Prevalence of Hpv Infection
3.1.3. Governments Initiatives Towards Std
3.1.4. Reimbursement for Std Testing
3.1.5. Increasing Std Screening Services
3.2. Restraint
3.2.1. Low Awareness Among People
3.2.2. Inadequate Infrastructure Provisions Such as Labs, Equipment and Supplies Majorly in West African Countries
3.2.3. Government Regulations for the Market Participants
3.3. Opportunity
3.3.1. National Screening Programs Across the World
3.3.2. Covering Untapped Market
3.3.3. Rising Awareness for Std and Other Disorders
3.3.4. Initiatives and Development in Healthcare Infrastructure

4. Market Segmentation
4.1. Std (Sexually Transmitted Disease) Diagnosis, by Disease Indication
4.1.1. Chlamydia Testing
4.1.2. Syphilis Testing
4.1.3. Gonorrhoea Testing
4.1.4. Herpes Simplex Virus Testing
4.1.5. Human Papilloma Virus Testing
4.1.6. Human Immunodeficiency Virus Testing
4.1.7. Others
4.2. Std (Sexually Transmitted Disease) Diagnosis, by Testing Devices
4.2.1. Laboratory Devices
4.2.2. Point of Care Devices
4.3. Std (Sexually Transmitted Disease) Diagnosis, by Technology
4.3.1. Pcrs (Polymerase Chain Reaction)
4.3.2. Immunochromatographic Capillary Flow Dipstick Technology (Assay)
4.3.3. Flow Cytometers
4.3.4. Differential Light Scattering
4.3.5. Enzyme Linked Immunosorbent Assay (Elisa)
4.3.6. Phone Chips (Microfluidics + Ict)
4.3.7. Portable / Bench Top / Rapid Diagnostic Kits
4.4. Std (Sexually Transmitted Disease) Diagnosis, by End Users
4.4.1. Government Organizations
4.4.2. Hospitals
4.4.3. Diagnostic Clinics

5. Competitive Landscape
5.1. Key Strategies
5.2. Key Company Analysis

6. Regional Analysis
6.1. North American Market Research and Analysis
6.1.1. United States
6.1.2. Canada
6.2. European Market Research and Analysis
6.2.1. Uk
6.2.2. Germany
6.2.3. Spain
6.2.4. France
6.2.5. Italy
6.2.6. Rest of Europe
6.3. Asia Pacific Market Research and Analysis
6.3.1. India
6.3.2. China
6.3.3. Japan
6.3.4. Rest of Asia-Pacific
6.4. Rest of the World Market Research and Analysis

7. Company Profiles (Company Overview, Product Portfolio, Recent Developments, Revenue Analysis)
7.1. Abbott Laboratories
7.2. Affymetrix, Inc.
7.3. Alere Inc.
7.4. Aposcience Ag
7.5. Bcr Biotech Inc.
7.6. Becton Dickinson and Company
7.7. Biocartis Sa
7.8. Biomerieux
7.9. Bio-Rad Laboratories Inc.
7.10. Cepheid Inc.
7.11. Danaher Corporation
7.12. Diasorin
7.13. Exogen Biotechnology, Inc.
7.14. Genmark Diagnostics
7.15. Hologic, Inc
7.16. Orasure Technologies
7.17. Qualigen, Inc.
7.18. Quidel Corporation
7.19. Roche Diagnostics
7.20. Thermo Fisher Scientific Inc.

List of Tables
Table 1 Global Std (Sexually Transmitted Disease) Diagnosis, by Disease Indication, 2016-2022 ($ Million)
Table 2 Global Chlamydia Testing 2016-2022 ($ Million)
Table 3 Global Syphilis Testing 2016-2022 ($ Million)
Table 4 Global Gonorrhoea Testing 2016-2022 ($ Million)
Table 5 Global Herpes Simplex Virus Testing 2016-2022 ($ Million)
Table 6 Global Human Papilloma Virus Testing 2016-2022 ($ Million)
Table 7 Global Human Immunodeficiency Virus Testing 2016-2022 ($ Million)
Table 8 Global Others 2016-2022 ($ Million)
Table 9 Global Std (Sexually Transmitted Disease) Diagnosis, by Testing Devices2016-2022 ($ Million)
Table 10 Global Laboratory Devices2016-2022 ($ Million)
Table 11 Global Point of Care Devices2016-2022 ($ Million)
Table 12 Global Std (Sexually Transmitted Disease) Diagnosis, by Technology 2016-2022 ($ Million)
Table 13 Global Pcrs (Polymerase Chain Reaction) 2016-2022 ($ Million)
Table 14 Global Immunochromatographic Capillary Flow Dipstick Technology (Assay) 2016-2022 ($ Million)
Table 15 Global Flow Cytometers 2016-2022 ($ Million)
Table 16 Global Differential Light Scattering 2016-2022 ($ Million)
Table 17 Global Enzyme Linked Immunosorbent Assay (Elisa) 2016-2022 ($ Million)
Table 18 Global Phone Chips (Microfluidics + Ict) 2016-2022 ($ Million)
Table 19 Global Portable / Bench Top / Rapid Diagnostic Kits 2016-2022 ($ Million)
Table 20 Global Std (Sexually Transmitted Disease) Diagnosis, by End Users2016-2022 ($ Million)
Table 21 Global Government Organizations2016-2022 ($ Million)
Table 22 Global Hospitals2016-2022 ($ Million)
Table 23 Global Diagnostic Clinics2016-2022 ($ Million)
Table 24 North American Market Research and Analysis by Country, 2016-2022 ($ Million)
Table 25 North American Market Research and Analysis by Disease Indication, 2016-2022 ($ Million)
Table 26 North American Market Research and Analysis by Testing Devices, 2016-12022 ($ Million)
Table 27 North American Market Research and Analysis by Technology, 2016-2022 ($ Million)
Table 28 North American Market Research and Analysis by End Users, 2016-2022 ($ Million)
Table 29 European Market Research and Analysis by Country, 2016-2022 ($ Million)
Table 30 European Market Research and Analysis by Disease Indication, 2016-2022 ($ Million)
Table 31 European Market Research and Analysis by Testing Devices, 2016-2022 ($ Million)
Table 32 European Market Research and Analysis by Technology, 2016-2022 ($ Million)
Table 33 European Market Research and Analysis by End User, 2016-2022 ($ Million)
Table 34 Asia Pacific Market Research and Analysis by Country 2016-2022, ($ Million)
Table 35 Asia Pacific Market Research and Analysis by Disease Indication 2016-2022, ($ Million)
Table 36 Asia Pacific Market Research and Analysis by Testing Devices 2016-2022, ($ Million)
Table 37 Asia Pacific Market Research and Analysis by Technology, 2016-2022, ($ Million)
Table 38 Asia Pacific Market Research and Analysis by End User, 2016-2022, ($ Million)
Table 39 Rest of the World Market Research and Analysis by Disease Indication, 2016-2022 ($ Million)
Table 40 Rest of the World Market Research and Analysis by Testing Devices, 2016-2022 ($ Million)
Table 41 Rest of the World Market Research and Analysis by Technology, 2016-2022 ($ Million)
Table 42 Rest of the World Market Research and Analysis by End User, 2016-2022 ($ Million)

List of Figures
Figure 1 Global Std Diagnosis Market Share by Disease Indication, 2016 and 2022 (%)
Figure 2 Global Std Diagnosis Market Share by Testing Devices, 2016 and 2022 (%)
Figure 3 Global Std Diagnosis Market Share by Technology, 2016 and 2022 (%)
Figure 4 Global Std Diagnosis Market Share by Geography 2016 and 2022 (%)
Figure 5 North American Market Research and Analysis, 2016-2022 ($ Million)
Figure 6 United States Market Research and Analysis, 2016-2022 ($ Million)
Figure 7 Canada Market Research and Analysis, 2016-2022 ($ Million)
Figure 8 European Market Research and Analysis, 2016-2022 ($ Million)
Figure 9 UK Market Research and Analysis, 2016-2022 ($ Million)
Figure 10 Germany Market Research and Analysis, 2016-2022 ($ Million)
Figure 11 Spain Market Research and Analysis, 2016-2022 ($ Million)
Figure 12 France Market Research and Analysis, 2016-2022 ($ Million)
Figure 13 Italy Market Research and Analysis, 2016-2022 ($ Million)
Figure 14 RoE Market Research and Analysis, 2016-2022 ($ Million)
Figure 15 Asia Pacific Market Research and Analysis, 2016-2022 ($ Million)
Figure 16 India Market Research and Analysis, 2016-2022 ($ Million)
Figure 17 China Market Research and Analysis, 2016-2022 ($ Million)
Figure 18 Japan Market Research and Analysis, 2016-2022 ($ Million)
Figure 19 Roapac Market Research and Analysis, 2016-2022 ($ Million)
Figure 20 Rest of the World Market Research and Analysis, 2016-2022 ($ Million)
Note: Product cover images may vary from those shown
3 of 4

Loading
LOADING...

4 of 4
  • Abbott Laboratories
  • Affymetrix, Inc.
  • Alere Inc.
  • Aposcience Ag
  • Bcr Biotech Inc.
  • Becton Dickinson and Company
  • Biocartis Sa
  • Biomerieux
  • Bio-Rad Laboratories Inc.
  • Cepheid Inc.
  • Danaher Corporation
  • Diasorin
  • Exogen Biotechnology, Inc.
  • Genmark Diagnostics
  • Hologic, Inc
  • Orasure Technologies
  • Qualigen, Inc.
  • Quidel Corporation
  • Roche Diagnostics
  • Thermo Fisher Scientific Inc.
Note: Product cover images may vary from those shown
5 of 4
Note: Product cover images may vary from those shown
Adroll
adroll